单心室姑息治疗患者的机械性房室瓣置换
1997至2021年,16例功能性单心室生理患者接受机械性房室瓣置换,中位年龄2岁,均使用St. Jude Medical机械瓣。手术死亡率38%(6/16),无移植生存率1年50%、5年37.5%、10年22%,心室功能保留者无移植生存率更高(P=0.01)。
要点
- 单心室患者机械性房室瓣置换手术死亡率38%(6/16),主要并发症包括出血(50%)和完全性心脏传导阻滞(19%)。
- 无移植生存率1年50%、5年37.5%、10年22%,心室功能保留者显著更高(P=0.01)。
- 瓣膜血栓6次事件见于5例患者,导致2例死亡和2例心脏移植。
核心结论
- 机械瓣置换伴显著发病率和死亡风险,虽可挽救约半数心室功能保留的患者,但术前应慎重考虑替代方案。
研究设计与样本
- 1997年至2021年连续16例功能性单心室生理患者接受机械性房室瓣置换的回顾性研究,主要结局为无移植生存率,次要结局为主要术后并发症。
主要发现
- 房室瓣置换中位年龄2岁(四分位距0.6-3.8岁),均使用St. Jude Medical机械瓣,中位尺寸24 mm(范围19-31 mm)。
- 手术死亡率38%(6/16),4例需体外膜肺氧合(ECMO),2例晚期死亡,3例心脏移植。
- 无移植生存率1年50%、5年37.5%、10年22%;心室功能保留者1年75% vs 25%、5年62.5% vs 12.5%、10年57% vs 0%(P=0.01)。
- 3例(19%)发生完全性心脏传导阻滞需永久起搏器,13例中6例(46%)达到Fontan完成(3例在Fontan时或之后手术)。
- 8例(50%)发生显著出血事件,3例发生主要脑血管意外;5例患者共6次瓣膜血栓事件,导致2例死亡和2例心脏移植。
临床怎么用
- 作者认为机械瓣置换伴显著发病率和死亡风险,术前应慎重考虑替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Atrioventricular valve (AVV) replacements in patients with single-ventricle circulations pose significant surgical risks and are associated with high morbidity and mortality. METHODS: From 1997 to 2021, 16 consecutive patients with functionally single-ventricle physiology underwent mechanical AVV replacement. Primary outcome was transplant-free survival. Secondary outcomes included major postoperative morbidity. RESULTS: The median age of AVV replacement was 2 years old (interquartile range 0.6-3.8 years). All AVV replacements were performed with a St. Jude Medical mechanical valve, median 24 mm (range, 19-31mm). Extracorporeal membrane oxygenation (ECMO) was required in 4 patients. Operative mortality was 38% (6/16). There were 2 late deaths and 3 transplants. Transplant-free survival was 50% at 1 year, 37.5% at 5 years, and 22% at 10 years. Transplant-free survival was higher for patients with preserved ventricular function (P = 0.01). Difference in transplant-free survival at 1 year was 75% vs 25%, at 5 years was 62.5% vs 12.5% and at 10 years was 57% vs 0%. Three (19%) patients had complete heart block requiring permanent pacemaker insertion. 6 of 13 patients (46%) patients reached Fontan completion (3 patients operated at/after Fontan). Significant bleeding events occurred in 8 patients (50%) with 3 patients suffering major cerebrovascular accidents. There were 6 events of valve thrombosis in 5 patients, resulting in 2 deaths and 2 heart transplants. CONCLUSIONS: Mechanical valve replacement carries significant morbidity and mortality risk. While it successfully salvages about half of patients with preserved ventricular function, careful consideration of alternative options should be made before embarking upon mechanical valve replacement.
引用
- Morgan CT, Chetan D, Varenbut J, et al. Mechanical atrioventricular valve replacement in patients with single ventricle palliation. Eur J Cardiothorac Surg. 2023. PMID: 37707524. doi:10.1093/ejcts/ezad317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。